emerging therapeutic approaches for tki-resistant cml
Published 2 years ago • 126 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
2:00
novel treatment strategies for patients with cml who are intolerant or resistant to available tkis
-
1:24
considerations for tki choice in frontline and r/r cml
-
3:18
predictors for tfr in cml: response duration, secondary treatment & frontline tki choice
-
1:22
unmet needs in cml: increasing treatment-free remission & accessibility to tkis
-
4:33
optimizing discontinuation of tyrosine kinase inhibitor treatment for chronic myeloid leukemia
-
5:09
cmml morphology-chronic myelomonocytic leukaemia for clinical and lab staff
-
25:36
optimizing access to high-quality, compliant leukopaks for allogeneic therapy development
-
4:03
release of information and psychotherapy notes
-
1:11
incorporating novel therapies into frontline all treatment
-
1:27
novel agents or imatinib for cml in the frontline setting?
-
1:26
emerging management options for aml
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
16:00
myeloid therapeutics
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
1:53
the future of leukemia treatment leans towards immunotherapy
-
0:55
the role of clinical trials in improving treatment options for scd
-
15:58
affini-t therapeutics
-
3:41
personalised medicine in cll: redefining the treatment approach
-
1:05
reprogramming leukemia cells into apcs as a novel therapeutic strategy for b-all
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
2:41
cell avidity as a predictor of t-cell efficacy